ArticleInternal and emergency medicine2025
Use of nicotine products, prescription drug products, and other methods to stop smoking by US adults in the 2022 National Health Interview Survey.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Bridging evidence gaps: the role of real-world data in tobacco harm reduction.Harm reduction journal · 2026Article
- Illegal markets for cigarettes and e-cigarettes.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The Lifetime Mortality Implications of Vaping and Smoking Initiated During Adolescence.American journal of preventive medicine · 2026Article
- Evaluating the substitutability of fruit versus menthol and tobacco-flavored e-cigarettes on combustible cigarette cessation: Randomized clinical trial protocol.Contemporary clinical trials communications · 2026Article
- Nicotine Risk Education and Its Impact on Knowledge, Perceptions, and Behavioral Intentions: A Scoping Review of U.S. Studies.International journal of environmental research and public health · 2026Article
- Repeated point-prevalence of switching away from smoking after electronic nicotine delivery systems (ENDS) purchase.Harm reduction journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent data on methods used by adults to stop smoking can inform tobacco control policies. Nationally representative Centers for Disease Control and Prevention survey data from the 2022 National Health Interview Survey (N = 27,651) were used to analyze populations of US adults who self-reported having stopped smoking cigarettes for 6 months or longer in the last year and the methods they used, or who did not stop smoking but tried in the last year (N = 1735). In 2022, an estimated 2.9 million [95% CI 2.5 million-3.2 million] US adults had stopped smoking in the past year. Most were male, non-Hispanic White, aged < 55 years, college-educated, identified as straight, were not depressed, and currently drank alcohol. The most popular methods used to stop smoking were nicotine products (53.9% [47.4-60.3%]; 1.5 [1.3-1.8] million adults), especially e-cigarettes in combination with other methods (40.8% [34.4-47.5%]; 1.2 [0.9-1.4] million) and e-cigarettes alone (26.0% [20.4-32.3%]; 0.7 [0.6-0.9] million). Prescription drug products (8.1% [5.3-11.8%]; 0.2 [0.1-0.3] million) and non-nicotine, non-prescription drug methods (6.3% (3.9-9.7%); 0.2 [0.1-0.3] million) were less popular. A further 13.1 [12.2-14.0] million tried but did not stop smoking. Compared to those who tried but didn't stop smoking, those who successfully stopped were more likely to be younger, degree-educated, and to use e-cigarettes to stop smoking. Many adults still attempt to stop smoking unaided. Interventions to reduce smoking could focus on populations that stopped smoking the least and encourage use of evidence-based methods.
Indexed as
Identifiers
39760947What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.